Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Malignant Neoplasm
47%
Helicobacter Pylori
47%
Colorectal Cancer
44%
Neoplasm
43%
Chronic Hepatitis C
42%
Mouse
38%
Chronic Hepatitis B
38%
Antivirus Agent
29%
Ropeginterferon Alpha2b
27%
Nonalcoholic Fatty Liver
27%
Liver Fibrosis
26%
Stomach Cancer
25%
Hepatitis C Virus
25%
Infection
24%
Fatty Liver
24%
Sorafenib
23%
Colon Cancer
22%
Inflammation
21%
Pancreas Cancer
21%
Combination Therapy
20%
Liver Disease
19%
Liver Cirrhosis
19%
Colorectal Carcinoma
19%
Phosphotransferase
18%
Duodenum Ulcer
18%
Chemotherapy
18%
Cohort Study
18%
Liver Cancer
17%
Hepatitis B Virus
17%
Cytotoxicity
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Cancer Growth
15%
Polysaccharide
15%
Lycium barbarum
15%
Chronic Kidney Failure
15%
Cisplatin
15%
Stomach Carcinoma
15%
Epidermal Growth Factor Receptor
14%
Clarithromycin
14%
Clinical Trial
14%
Prevalence
14%
Caspase 3
13%
Adverse Event
13%
Helicobacter Infection
13%
Pharmacokinetics
13%
Lipopolysaccharide
13%
Metaplasia
12%
Cytolethal Distending Toxin
12%
Cetuximab
12%
Heme Oxygenase 1
12%
Peginterferon
12%
Overall Survival
12%
Alanine Aminotransferase
11%
Disease
11%
Gastrointestinal Disease
11%
Nitric Oxide
11%
Interferon
11%
Transforming Growth Factor
10%
Western Blot
10%
Recurrent Disease
10%
Ulcer
10%
Glecaprevir Plus Pibrentasvir
10%
Campylobacter Jejuni
9%
Fibrosis
9%
Bilirubin
9%
Levofloxacin
9%
Recurrent Peptic Ulcer
9%
Lipoteichoic Acid
9%
Bevacizumab
9%
Heart Failure
9%
Proton Pump Inhibitor
9%
Reactive Oxygen Metabolite
9%
Cytokine
9%
Ribavirin
9%
Randomized Controlled Trial
9%
Amoxicillin
9%
Protein P53
9%
Tumor Necrosis Factor
9%
Survival Rate
9%
Prostate Cancer
8%
Mitogen Activated Protein Kinase
8%
Anti-Inflammatory Drug
8%
Hepatitis C
8%
Carcinogenesis
8%
Antioxidant
8%
Fluorouracil
8%
Statin (Protein)
8%
Receptor
8%
Sofosbuvir
8%
Metastasis
8%
Entecavir
7%
Glucose Regulated Protein 78
7%
Esomeprazole
7%
Mouse Model
7%
Hemodialysis
7%
Vasculotropin
7%
Diabetes Mellitus
7%
Antiinfective Agent
7%
Defined Daily Dose
7%
Medicine and Dentistry
Hepatocellular Carcinoma
69%
Colorectal Cancer
58%
Neoplasm
55%
Liver Cirrhosis
34%
Helicobacter Pylori
34%
Malignant Neoplasm
34%
Stomach Cancer
33%
Chronic Hepatitis C
32%
Chronic Hepatitis B
32%
Cohort Analysis
27%
In Vitro
26%
Pylorus
26%
Cancer Cell
25%
Diabetes
23%
Nonalcoholic Fatty Liver
23%
Systematic Review
22%
Metastatic Carcinoma
22%
Colonoscopy
21%
Meta-Analysis
21%
Randomized Controlled Trial
20%
Surgery
20%
Fatty Liver
19%
Liver Fibrosis
18%
Infection
18%
Hepatitis C Virus
18%
Prevalence
18%
Odds Ratio
18%
Antivirus Agent
18%
Liver Disease
17%
Liver Cancer
17%
Platelet
16%
Duodenum Ulcer
16%
Duodenal Bulb
16%
Ulcer
15%
Metaplasia
15%
Cancer
14%
Overall Survival
14%
Disease
14%
Helicobacter Infection
14%
Radiofrequency Ablation
13%
Acute Pancreatitis
12%
Cancer Staging
12%
Diagnosis
12%
Pancreas Cancer
12%
Fibrosis
12%
Carcinogenesis
11%
Colon
11%
Survival Rate
11%
Upper Gastrointestinal Endoscopy
11%
Hazard Ratio
11%
Programmed Cell Death
11%
Stomach Carcinoma
11%
Endoscope
11%
Echography
10%
Infection Rate
10%
Carcinoma
10%
Breast Cancer
10%
Colon Cancer
10%
Upregulation
10%
Duodenum Mucosa
10%
Diabetes Mellitus
10%
Medicine
10%
Polyp
10%
Recurrent Disease
10%
Biopsy
10%
Symptom
10%
Cancer Stem Cell
10%
Transcatheter Arterial Chemoembolization
9%
Computer Assisted Tomography
9%
Gastritis
9%
Cancer Growth
9%
Lymph Node Metastasis
9%
Intention-to-Treat Analysis
9%
Alanine Aminotransferase
9%
Endoscopic Submucosal Dissection
9%
Hookworm Infection
9%
Reflux Esophagitis
9%
Alcohol Liver Disease
9%
Supplementation
9%
Chronic Kidney Disease
9%
Bilirubin
9%
Intussusception
9%
Duodenum
8%
Clinical Trial
8%
Clarithromycin
8%
Colorectal Carcinoma
8%
Chromosome Segregation
8%
Drug Therapy
8%
Ex Vivo
8%
Catenin
8%
Mitogen-Activated Protein Kinase
8%
Screening
7%
Stomach Adenocarcinoma
7%
Bleeding
7%
Endoscopy
7%
Hepatitis C
7%
Gut Microbiota
7%
Liver Abscess
7%
Esophageal Cancer
7%
Ras
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
51%
Catenin
16%
Carcinogenesis
15%
Cancer Stem Cell
14%
Survival Rate
13%
Stem Cell
13%
Mouse
12%
Randomized Controlled Trial
12%
Colon
12%
Tumor Progression
11%
Cancer Staging
11%
Cell Proliferation
11%
Cytotoxicity
11%
Messenger RNA
10%
Chromosome Segregation
9%
Clinical Trial
9%
Interleukin 10
8%
HBsAg
8%
Hepatitis B Virus
7%
Epidermal Growth Factor Receptor
7%
Radiofrequency
7%
Prevalence
7%
P53
7%
Retrospective Study
6%
Monocyte
6%
Eicosanoid Receptor
6%
Helicobacter Pylori
6%
Cross Sectional Study
6%
Overall Survival
6%
Protein Kinase C
6%
Glucose-Regulated Protein
6%
Isoform
6%
FOXM1
6%
Tumor Suppressor Protein
6%
Bilirubin
6%
Vascular Endothelial Growth Factor
6%
Body Composition
6%
Western Blot
5%
Cohort Study
5%
Solution and Solubility
5%
Gene Expression
5%
Hydrogen Bond
5%
Egg Lecithin
5%
Molecular Weight
5%
Extracellular Signal-Regulated Kinases
5%
interferon
5%
Interferon
5%